Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT05890183 · University of California, Los Angeles

Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode

What this study is about

The participants in the study will receive psychiatric treatment at the UCLA Aftercare Research Program. All participants in this 12-month RCT will receive cognitive training. Half of the patients will also be randomly assigned to the aerobic exercise and strength training condition, and the other half will be randomly assigned to the Healthy Living Group condition.

View original scientific description

The participants in the study will receive psychiatric treatment at the UCLA Aftercare Research Program. All participants in this 12-month RCT will receive cognitive training. Half of the patients will also be randomly assigned to the aerobic exercise and strength training condition, and the other half will be randomly assigned to the Healthy Living Group condition. The primary outcome measures are improvement in cognition and level of engagement in the in-group and at-home exercise sessions. Increases in the level of the patient's serum brain-derived neurotropic factor (specifically Mature BDNF) which causes greater brain neuroplasticity and is indicator of engagement in aerobic exercise, will be measured early in the treatment phase in order to confirm engagement of this target. In order to demonstrate the feasibility and portability of this intervention outside of academic research programs, the interventions will be provided via videoconferencing. The proposed study will incorporate additional methods to maximize participation in the exercise condition, including the use of the Moderated Online Social Therapy (MOST) platform to enhance motivation for treatment based on Self-Determination Theory principles, and a "bridging" group to help the participants generalize gains to everyday functioning. In addition, the exercise group participants will receive personally tailored text reminders to exercise.

Interventions

BEHAVIORAL

Cognitive training

This systematic cognitive training program will be delivered by telehealth sessions in which each patient logs into their Posit Science account and joins a Zoom videoconference with 4-8 other patients and two cognitive coaches. The first 12 weeks focus on neurocognitive training and the second 12 weeks focus on social cognitive training. Patients have two CT sessions on each of two days each week to complete 4 hours/week of computerized cognitive training for the first 6 months. Thus, each patient will receive 48 hours of neurocognitive training and 48 hours of social cognitive training in the first 6 months. In the second 6 months, the number of hours per week is trimmed to half the dosage.

BEHAVIORAL

Aerobic Exercise Program

The Aerobic Exercise Program group sessions will be conducted by Zoom videoconferencing. The group exercise training sessions are a combination of moderate intensity aerobic conditioning (1-min intervals) and moderate to high intensity strength and callisthenic conditioning (1-min intervals). The exercise dosage goal is 150 minutes/week of moderate aerobic activity, over 4 days, including for the first 6 months two group sessions (45 min duration) and two individual sessions personalized to the patient's choice of exercise (30 min duration) in the target heart rate zone. After the first 6 months, the group exercise sessions are once a week but the goal remains 150 minutes/week of moderate exercise.

BEHAVIORAL

Moderated Online Social Therapy (MOST)

MOST combines: (1) evidence-based, interactive, user-directed web-based interventions; (2) secure and supportive peer-to-peer web-based social networking; (3) moderator support; and (4) on-demand web chat with registered clinicians. A Motivation Track on the MOST platform will be used to encourage intrinsic motivation for self-improvement for both groups and, for the CT\&E group, involvement in our exercise program.

BEHAVIORAL

Chorus Participatory Text Messaging Program

The Chorus text messaging program is a web-based application that allows clinicians to create a broad range of automated SMS text messages and interactive voice responses using a simple, accessible graphical user interface. It will target encouragement to exercise and social feedback on completed exercise in the CT\&E group.

BEHAVIORAL

Healthy Living Group (HLG)

The Healthy Living Group (HLG) meets two sessions/week to discuss wellness, nutrition, insight, recovery, independent living, social skills, and hobbies for the first 6 months and then one session/week for the next 6 months.

Primary outcome measures

Change in Serum Mature BDNF

Time frame: Outcome is change from baseline to 2 weeks.

A brain neurotrophic factor that stimulates synaptic plasticity and neurogenesis

Change in Serum Mature BDNF

Time frame: Outcome is change from baseline to 3 months.

A brain neurotrophic factor that stimulates synaptic plasticity and neurogenesis

Change in Overall Composite T-score from the MATRICS Consensus Cognitive Battery (MCCB)

Time frame: Outcome is change from baseline to 3 months.

A summary of overall cognitive performance on the MATRICS Consensus Cognitive Battery

Change in Overall Composite T-score from the MATRICS Consensus Cognitive Battery (MCCB)

Time frame: Outcome is change from baseline to 6 months.

A summary of overall cognitive performance on the MATRICS Consensus Cognitive Battery

Change in Intrinsic Motivation Inventory for Schizophrenia Research (IMI-SR)

Time frame: Outcome is change from baseline to 3 months.

21 items that assess motivational experiences in three domains: Interest/enjoyment, perceived choice, and value/usefulness.

Change in Intrinsic Motivation Inventory for Schizophrenia Research (IMI-SR)

Time frame: Outcome is change from baseline to 6 months.

21 items that assess motivational experiences in three domains: Interest/enjoyment, perceived choice, and value/usefulness.

Attendance at Exercise Sessions for First Three Months

Time frame: First Three Months After Baseline

Proportion of group sessions completed by the participants in the exercise group

Attendance at Exercise Sessions for First Six Months

Time frame: First Six Months After Baseline

Proportion of group sessions completed by the participants in the exercise group

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • a first episode of a psychotic illness that began within the past three years;
  • a diagnosis by DSM-5 of schizophrenia, schizoaffective disorder, or schizophreniform disorder;
  • age 18 to 45 years of age;
  • sufficient acculturation and fluency in the English language to avoid invalidating research measures; and
  • residence likely to be within commuting distance of the UCLA Aftercare Research Program.

Exclusion criteria

  • premorbid IQ less than 70;
  • evidence of a known neurological disorder (e.g., epilepsy) or significant head injury;
  • evidence of moderate or severe substance use disorder within the six months prior to the first episode or evidence of a substance-induced psychosis.

Where

  • Los Angeles, California

Collaborators

National Institute of Mental Health (NIMH)

Related conditions & keywords

SchizophreniaSchizophreniform DisorderSchizoaffective DisorderFirst-Episode SchizophreniaCognitive RemediationPhysical ExerciseBrain Derived Neurotrophic FactorTelehealth InterventionModerated Online Social Therapy (MOST)Motivational Text Messaging Program (Chorus)

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Jan 2, 2025 · Source of record for eligibility and locations

📊
1 of 100 participants interested
1% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Los Angeles

California

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Schizophrenia Trials by City

Browse all schizophrenia clinical trials in these cities — not just this study.

Looking for Schizophrenia Treatment in Los Angeles?

Join others in California exploring innovative treatment options through clinical research

Schizophrenia Treatment Options in Los Angeles, California

If you're searching for Schizophrenia treatment in Los Angeles, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Los Angeles and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Schizophrenia. All study-related care is provided at no cost to participants.

Local Sites
1 locations in California
Now Enrolling
Up to 100 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Schizophrenia?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Schizophrenia

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Schizophrenia Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT05890183. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.